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Executive summary 
The statistics in this report present information collected through the National Drug 
Treatment Monitoring System (NDTMS) about young people under the age of 18 who 
received specialist substance misuse interventions in England during 2016-17 (that is, 
between 1 April 2016 and 31 March 2017).  
 
Specialist substance misuse services saw fewer young people in 2016-17 than in the 
previous year (16,436, a decrease of 641 or 4% compared to 2015-16). This continues 
a downward trend, year-on-year, since a peak of 24,053 in 2008-09.  
 
Two-thirds of the young people accessing specialist substance misuse services were 
male (66%) and half (50%) of all persons were aged 16 or over. Females in treatment 
had a lower median age (15) than males (16), with 28% of females under the age of 15 
compared to 22% of males. 
 
Although the number of younger children (under 14) in treatment is relatively low, it has 
increased from 1,219 in 2014-15 to 1,342 in 2016-17 (a 10% increase). The recently 
published schools survey ‘Smoking, drinking and drug use among young people in 
England’ indicated an increase in lifetime prevalence of drug use among 11-15 year 
olds in the latest year (2016). Although these findings are not directly related, they may 
indicate that the increasing numbers coming into treatment do reflect a change in 
patterns of use. However, it is too early to draw any firm conclusions and data over a 
longer period is needed. Any substance misuse among this age group is concerning, as 
they are likely to be at risk of other harms than alcohol or drug use alone. In these 
cases, safeguarding needs to be a priority, and wider aspects of the child’s life needs to 
be addressed, in addition to their substance misuse. 
 
The most common drug that young people presented to treatment with continued to be 
cannabis. Around 9 out of 10 (88%) of young people in specialist services said they 
have a problem with this drug compared to 87% in 2015-16. The proportion of young 
people in treatment reporting cannabis as the primary substance have been on an 
upward trend since 2005-06, although numbers have decreased slightly in the last 3 
years. 
 
Alcohol is the next most commonly cited problematic substance with just under half of 
the young people in treatment (49%) seeking help for alcohol misuse during 2016-17. 
However, numbers in treatment for alcohol problems have been declining steadily in 
recent years and this figure is much lower than the two-thirds (67%) with alcohol 
problems reported in 2009-10. 
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Alongside cannabis and alcohol, young people in specialist substance misuse services 
used a range of substances. Of those who were in contact with services, 1,815 cited 
problematic ecstasy use (11%), 1,473 cocaine use (9%), 491 amphetamine use (3%), 
and 585 (4%) with concerns around the use of new psychoactive substances (NPS).  
 
The proportion of young people reported by specialist services as having problems with 
NPS fell by 45% (from 1,056 in 2015-16 to 585 in 2016-17). 2016-17 is the first year 
since data on NPS use was added to NDTMS that the number of young people in 
treatment with problematic NPS use has decreased. However, local areas need to 
ensure that services are accessible and appropriate for young people who are having 
problems with NPS, so they can be confident that this pattern reflects need.  
 
The most common routes into specialist substance misuse services were from 
education provision (29%), youth justice services (25%), and children’s social care 
(15%). The proportion of referrals from the youth justice system has declined in recent 
years while the proportion of referrals from education provision has increased.  
 
The majority of young people presenting to specialist substance misuse services have 
other problems or vulnerabilities related to their substance use (such as having mental 
health problems, being ‘looked after’1 or not being in education, employment or 
training2) or wider factors that can impact on their substance use (such as offending, 
self-harming, experiencing sexual exploitation or domestic abuse). Of the 17 
vulnerability items collected via the NDTMS, 80% of young people who have entered 
treatment in 2016-17 disclosed 2 or more vulnerabilities. Therefore, specialist services 
need to work effectively with a range of other agencies to ensure that all the needs of a 
young person are met. 
 
Following on from the last 2 years, data on sexual exploitation are included in this 
report. Fourteen per cent (14%) of females presenting to treatment services in 2016-17 
reported experience of sexual exploitation (the same proportion as in 2015-16). The 
proportion of males was much lower at 2% (a change from 1% of males in 2015-16). 
 
Waiting times to gain access to treatment were short. The average (mean) wait for 
young people to start their first specialist intervention was two days. Almost all (98%) of 
the 17,445 first interventions starting in 2016-17 had waiting times of 3 weeks or under, 
with 81% receiving a first intervention on the day they were referred. 
 
 
                                            
 
1
 as defined under section 20 of the Children Act 1989 
2
 commonly referred to as ‘NEET’ 
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Of the 10,834 young people leaving services in 2016-17, 82% (8,842) did so in a 
planned way, no longer requiring specialist interventions. This is a 2% higher treatment 
completion rate than last year, which suggests that specialist substance misuse 
services in England are responding well to the needs of young people who have alcohol 
and drug problems, and are helping young people to overcome their substance misuse 
problems. 
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1. Background and policy context 
1.1 These statistics and their use 
The statistics in this report present information collected through the National Drug 
Treatment Monitoring System (NDTMS) about young people under the age of 18 who 
receive specialist substance misuse interventions in England. The information relates to 
all substances young people (YP) in specialist services sought help for, including 
alcohol.  
 
The statistics are used to: 
 
 inform the commissioning of specialist services for young people with drug 
and/or alcohol problems 
 monitor national availability and effectiveness of specialist substance misuse 
services for young people 
 monitor trends and shifts in patterns of drug and alcohol use among young 
people attending specialist services to inform future local and national public 
health policy 
 provide evidence about the benefits of attending specialist substance misuse 
services to young people and their families 
 inform the Government drug strategy  
 
The statistics in this report should therefore be considered as part of a wider picture 
around the health needs of young people and prevention services for vulnerable young 
people.   
 
More detail on the methodologies used to compile these statistics and the processes in 
place to ensure data quality can be found at: 
https://www.ndtms.net/resources/secure/Quality-and-Methodology-NDTMS-2016-17.pdf 
  
If an error is identified in any of the information that has been included in this report, 
then the processes described in the Public Health England (PHE) revisions and 
correction policy will be adhered to. The policy can be found here at: 
www.gov.uk/government/organisations/public-health-england/about/statistics  
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1.2 Specialist substance misuse services for young people 
Specialist substance misuse services for young people are distinct from adult treatment 
services because young people’s alcohol and drug problems tend to be different to 
those of adults and so they need a different response. This includes being child centred, 
considering the age and maturity of young people, supporting the young people to 
ensure they are not mixing with more problematic adult drug users and acting on 
safeguarding concerns. 
 
The role of specialist substance misuse services is to support young people to address 
their alcohol and drug use, to reduce the harm it causes them and prevent it from 
becoming a greater problem as they get older. Services should operate as part of a 
wider network of universal and targeted prevention services, which aim to support 
young people with a range of issues and help them to build their resilience3. 
 
1.3 Prevalence of alcohol and drug use among young people 
NDTMS statistics do not provide an indication of the levels of need for young people’s 
specialist substance misuse services. The main prevalence data for trends in substance 
use among young people is the biennial schools survey ‘Smoking, drinking and drug 
use among young people in England’ for 11-15 year olds. The latest report for 2016 can 
be found at: digital.nhs.uk/catalogue/PUB30132 
 
The 2016 schools survey reported an increase in lifetime prevalence of drug use, from 
15% in 2014 to 24% in 2016, following a longer term falling trend. Part of this increase 
in overall drug use can be explained by the addition of questions on nitrous oxide (NO) 
and new psychoactive substances (NPS). However, even allowing for these, the 
estimate for 2016 is 21% which remains a large increase from 15% in 2014. One tenth 
(10%) of pupils said that they had taken drugs in the last month, up from 6% in 2014. 
The authors noted that this increase in drug use among young people has not been 
observed in other data sources and therefore needs to be treated with caution.   
 
The schools survey shows that 44% of pupils had ever drunk alcohol. By the age of 15, 
73% of teenagers had tried alcohol and almost a quarter of 15 year olds reported that 
they had an alcoholic drink in the last week. This figure is not comparable with earlier 
surveys due to a change in methodology, but is regarded by the authors as more 
accurate than estimates of lifetime prevalence from previous iterations of this survey. It 
                                            
 
3
 Universal services can include school-based approaches to drug and alcohol education and prevention, 
delivered through PSHE. Targeted services can include specific interventions delivered to young people at 
significant risk of developing drug or alcohol problems, such as those involved in youth justice services, or 
non-mainstream education. 
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is important to note that 9% of pupils said they had been drunk in the last 4 weeks, 
including 7% of pupils who had been drunk once or twice, and 2% more often. Girls 
(11%) were more likely to have been drunk in the last 4 weeks than boys (7%). 
England, however, still has a relatively high incidence of regular drinking, drunkenness 
and cannabis use among 15 year olds compared to other European countries4. 
 
Prevalence statistics for young adults aged 16-24 are included in the ‘Drug Misuse: 
Findings from the 2016-17 Crime Survey for England and Wales’ (CSEW) report. The 
report has consistently found that younger people are more likely to have taken drugs in 
the last year than older people. The level of any drug use in the last year was highest 
among 16 to 19 year olds (16.5%) and 20 to 24 year olds (21.2%). Although the latest 
2016-17 report shows that there is a long term trend of decreasing drug use reported 
among the 16 to 24 age group, there are indications of a slight increase in use in recent 
years. The ‘Smoking, Drinking and Drug Use’ survey discussed above notes that 
unpublished analysis from the 2016-17 CSEW report showed that the proportion of 16 
and 17 year olds reporting use in the last year was unchanged between 2014-15 and 
2016-17 (14%).  
 
The latest CSEW report can be found at: https://www.gov.uk/government/statistics/drug-
misuse-findings-from-the-2016-to-2017-csew 
 
1.4 Other risk factors affecting young people  
Acute harm from drug and alcohol use can happen to anybody, but problematic drink 
and drug use among under-18s rarely occurs in isolation and is frequently a symptom of 
wider problems.  
 
Evidence suggests that there are a number of risk factors (or vulnerabilities) associated 
with young people misusing substances, being harmed by those substances and going 
on to develop drug or alcohol problems as adults. These risk factors include 
experiencing domestic abuse and sexual exploitation, truanting from school, offending, 
early sexual activity, antisocial behaviour, mental health problems and being exposed to 
parental substance misuse.  
 
Findings from the Health Behaviour in School-aged Children (HBSC) report4 also 
suggest that while drinking alcohol during adolescence is to some extent a normative 
aspect of young people’s development, excessive drinking and drunkenness (and 
particularly early initiation to drinking) is associated with increased risk of injury, 
unplanned and unprotected sex, and alcohol disorders and dependency. It also reports 
                                            
 
4
 Health Behaviour in School-aged Children (HBSC): World Health Organization Collaborative Cross National 
Study (Brooks, F. et al., 2015) 
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that cannabis use during adolescence has been associated with decreased 
performance on learning and memory tasks, lower academic attainment, other illicit 
drug dependency, and suicide attempts. 
 
An analysis of the HBSC survey for England carried out for PHE showed that among 
girls, those with the lowest life satisfaction were found to be more likely to have both 
consumed alcohol in the last month and ever been drunk (consumed alcohol to excess), 
and ten times as likely to report having smoked tobacco in the last month than those 
with the highest life satisfaction. They were also more likely to report having ever used 
cannabis, having had sex, and being involved in physical fighting. The report can be 
found at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/621069/H
ealth_behaviour_in_school_age_children_wellbeing_of_adolescent_girls.pdf 
 
PHE’s National Child and Maternal Health Intelligence Network is also available to local 
authorities and provides a wide-range of authoritative data, evidence and practice 
related to children's, young people's and maternal health. A guidance page which 
explains how health professionals can use child and maternal health data and 
intelligence to help make decisions about the planning and provision of services is 
available here: https://www.gov.uk/guidance/child-and-maternal-health-data-and-
intelligence-a-guide-for-health-professionals 
 
1.5 Assessment of quality and robustness of 2016-17 NDTMS  
community data 
NDTMS data is routinely collected by Public Health England (PHE). Drug and alcohol 
treatment providers submit a monthly extract and this is checked for data quality by 
local NDTMS teams. Data submissions are aggregated and reconciled against previous 
submissions to create a single national data submission. PHE operates a continual 
programme of improvement and treatment providers work with their local NDTMS team 
to improve each monthly submission throughout the year. 
 
NDTMS data quality is extremely important as it provides PHE with assurances that the 
data is an accurate representation of actual activity and it is therefore usable and 
reliable. It also gives confidence to the user of these statistics that the appropriate 
checks and balances have been applied. 
 
Table 1.5.1 provides an overview of the quality of data submitted to NDTMS by young 
people treatment services since 2014-15. The proportion of valid records received out of 
all submitted records along with the proportion of records received without errors or 
warnings are included as they indicate the general level of data quality across the broad 
spectrum of information collected at each monthly data submission. Three additional 
indicators are also included below that report on the proportion of duplicate or 
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overlapping treatment interventions and episodes. These are reported as they provide a 
sense of how accurate and efficient record keeping is at treatment provider level. A low 
proportion is desirable as it demonstrates robust administrative functions at a national 
level.  
 
Table 1.5.1 Data quality of NDTMS 
 
Data quality measure 2014-15 2015-16 2016-17 
Proportion of submitted records that were valid 100.00% 100.00% 100.00% 
Proportion of records without errors or warnings 99.93% 99.95% 99.96% 
Proportion of duplicate treatment episodes recorded at 
the same provider 0.17% 0.00% 0.00% 
Proportion of overlapping treatment episodes recorded at 
the same provider 0.08% 0.04% 0.01% 
Proportion of duplicate treatment interventions recorded 
at the same provider 0.11% 0.00% 0.00% 
 
More detailed information on NDTMS data collection and full definitions for the data 
quality measures recorded in Table 1.5.1 can be found at: 
https://www.ndtms.net/resources/secure/Quality-and-Methodology-NDTMS-2016-17.pdf 
 
In addition to the data quality checks taken at data submission, there are data quality 
checks and validation rules used in the production of this report. The rate of completion 
for report items range from 100% to 97%. Where items are under 100% this implies it is 
either due to missing data for that item or conflicting information has been entered for 
the same individual.  
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2. Characteristics of clients 
During 2016-17 (between 1 April 2016 and 31 March 2017), 16,436 young people aged 
9-175 were reported to the NDTMS as in contact with treatment services. This is a 4% 
decrease (641 individuals) from 2015-16 (17,077 young people). Comparisons with 
earlier years are included in section 5. 
 
2.1 Age and gender of all young people 
The age and gender of young people at their first point of contact with the treatment 
system in 2016-17 are reported in table 2.1.1 and figure 2.1.1. The majority of young 
people in treatment were male (66%), which is a higher percentage than in the general 
population of 9-17 year olds where males of the same age account for 51% (ONS, 
2016)6. Half of all young people in treatment were aged 16 or over. Overall, females 
accessing services were younger (median age of 15), compared to males (median age 
of 16).  
 
Although the number of younger children (under 14) in treatment was relatively low, it 
has increased since 2014-15 (see section 5.1). Any substance misuse among this age 
group is concerning, as they are likely to be at risk of harm. In these cases, 
safeguarding needs to be a priority, with wider aspects of the child’s life addressed, in 
addition to their substance misuse. 
 
The recently published schools survey ‘Smoking, drinking and drug use among young 
people in England’ indicated an increase in lifetime prevalence of drug use among 11-
15 year olds in the latest year (2016), against a longer term falling trend. This finding is 
not directly related to the increased numbers of younger children in treatment reported 
here, as the data sources differ in terms of methodology, the time period and the age 
range in which the increase was observed. In addition, the survey authors noted that the 
increase in drug use among young people they identified has not been observed in 
other data sources and therefore needs to be treated with caution. It is therefore too 
early to draw any firm conclusions about whether the increasing numbers coming into 
treatment in this age group do reflect a change in patterns of use. Data over a longer 
period is needed to establish this. 
 
                                            
 
5
 For age methodology please refer to the Quality and Methodology information document here: 
https://www.ndtms.net/resources/secure/Quality-and-Methodology-NDTMS-2016-17.pdf 
6
 Annual mid-year population estimates, 2016 
http://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/bulletins/a
nnualmidyearpopulationestimates/mid2016 
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Table 2.1.1 Age and gender of all young people in treatment 2016-17 
 
Age 
Female Male Persons 
n % n % n % 
Under 12 12 0% 56 1% 68 0% 
12-13 105 2% 179 2% 284 2% 
13-14 396 7% 594 6% 990 6% 
14-15 1,061 19% 1,549 14% 2,610 16% 
15-16 1,555 27% 2,791 26% 4,346 26% 
16-17 1,315 23% 2,794 26% 4,109 25% 
17-18 1,225 22% 2,804 26% 4,029 25% 
Total clients 5,669 100% 10,767 100% 16,436 100% 
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Figure 2.1.1 Age and gender distribution of all young people in contact with treatment services 2016-17 
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2.2 Ethnicity of all young people in treatment 
Table 2.2.1 shows the ethnicity of young people in treatment services. Where reported, 
most clients (76%) were white British. This is comparable to the general population 
where the latest census (2011) showed that 78% of young people aged 10 to 17 were 
white British.7 Among the remaining clients, 4% were other white, 3% were white and 
black Caribbean and 3% Caribbean with no more than 2% reporting any other ethnicity. 
 
Table 2.2.1 Ethnicity of all young people in treatment 2016-17 
 
Ethnicity n % 
White British 12,458 76% 
Other White 610 4% 
White & Black Caribbean 522 3% 
Caribbean 460 3% 
Other Mixed 321 2% 
African 302 2% 
Not Stated 243 1% 
Other Black 224 1% 
Other 220 1% 
Bangladeshi 181 1% 
Pakistani 180 1% 
Other Asian 170 1% 
White & Asian 152 1% 
White Irish 103 1% 
White & Black African 100 1% 
Indian 98 1% 
Chinese 7 0% 
Total 16,351 100% 
Missing or inconsistent data 85   
Total 16,436   
 
 
 
 
 
 
 
  
                                            
 
7
 Ethnic group by age in England 
https://www.nomisweb.co.uk/census/2011/LC2109EWLS/view/2092957699?rows=c_age&cols=c_ethpuk11 
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2.3 Substance use 
Table 2.3.1 shows the primary substance use (the substance that brought the young 
person into treatment at the point of triage/initial assessment) and adjunctive substance 
use (other substances cited by the young person) of young people in treatment in 2016-
17. If a young person was seen at multiple service providers or multiple times within the 
year, the substance(s) recorded at their latest treatment episode in the year are 
reported here (for further details, see https://www.ndtms.net/resources/secure/Quality-
and-Methodology-NDTMS-2016-17.pdf). 
 
Eighty-eight per cent (88%) of young people reported either primary or adjunctive 
cannabis use compared to 87% last year. Alcohol was the second most cited substance 
(49%). However, numbers in treatment for alcohol misuse have been declining steadily 
in recent years, and this figure is much lower compared to the 67% reported in 2009-10. 
The proportion of young people citing ecstasy has increased to 11% in 2016-17 from 
9% in 2015-16, while the proportion citing amphetamines has decreased to 3% from 7% 
and the proportion citing new psychoactive substances (NPS) has decreased to 4% 
from 6%. Nine per cent (9%) of young people cited powder cocaine use and this was 
similar to 2015-16. 
 
The median age of young people in specialist services was 15 years. The small 
numbers in treatment for primary heroin and crack use had a higher median age of 17. 
Primary cannabis, alcohol, ecstasy and solvent users have the lowest median age of 
15. A more detailed breakdown of substances by age is shown in table 2.3.2. Trends in 
presenting substances can be found in section 5.  
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Table 2.3.1 Substance use of all young people in treatment 2016-17 
 
Substance 
Primary Adjunctive^ Total Primary 
n % n % n % 
median 
age 
Cannabis 12,712 77% 1,737 11% 14,449 88% 15 
Alcohol 2,465 15% 5,593 34% 8,058 49% 15 
Ecstasy 340 2% 1,475 9% 1,815 11% 15 
Cocaine 254 2% 1,219 7% 1,473 9% 16 
New psychoactive 
substances 
213 1% 372 2% 585 4% 16 
Amphetamines 71 0% 420 3% 491 3% 16 
Solvents 128 1% 302 2% 430 3% 15 
Heroin 71 0% 27 0% 98 1% 17 
Crack 16 0% 67 0% 83 1% 17 
Other opiates◊ 23 0% 60 0% 83 1% 16 
Other‡ 133 1% 563 3% - - 16 
Nicotine (adjunctive use only) - - 2,711 16% - - - 
Total 16,426 100%           
Missing, misuse free or 
inconsistent data 
10             
Total including missing 16,436             
 
 
^ Adjunctive percentages are out of all young people in treatment (16,436) 
◊ ‘Other opiates' include methadone. 
‡
 ‘Other’ incorporates a number of different substance categories which are not shown elsewhere in the table. 
A single young person may be counted under both primary and adjunctive ‘other’ if the substances are from 
different categories. Therefore, primary and adjunctive users cannot be summed to give a total number of 
users.
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Figure 2.3.1 Substance use of all young people in treatment (any citation – primary and adjunctive) 2016-17^ 
 
 
 
 
^ Figure 2.3.1 excludes young people citing other substances as primary and adjunctive use cannot be summed. Please see note 
‡ 
under table 2.3.1
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Table 2.3.2 Substance use (primary and adjunctive combined) by age of all young people in treatment 2016-17^ 
 
Substance 
Under 13∆ 13-14 14-15 15-16 16-17 17-18 
n % n % n % n % n % n % 
Cannabis 247 70% 807 82% 2,261 87% 3,921 90% 3,682 90% 3,531 88% 
Alcohol 175 50% 473 48% 1,352 52% 2,095 48% 2,000 49% 1,963 49% 
Ecstasy 18 5% 64 6% 257 10% 494 11% 503 12% 479 12% 
Cocaine 8 2% 28 3% 117 4% 305 7% 412 10% 603 15% 
New psychoactive substances 10 3% 21 2% 75 3% 142 3% 164 4% 173 4% 
Amphetamines * - 10* 1%* 60* 2%* 120* 3%* 145* 3%* 155* 4%* 
Solvents 31 9% 32 3% 81 3% 129 3% 84 2% 73 2% 
Opiates ‡ 0 0% * - 13 0% 28 1% 50 1% 85 2% 
Crack 0 0% * - * - 11 0% 20 0% 48 1% 
Total▼ 352 100% 990 100% 2,610 100% 4,346 100% 4,109 100% 4,029 100% 
 
 
^ Primary and adjunctive use are combined in this table, therefore a young person may be counted for more than once in this table. See table 2.3.1 for a 
breakdown of primary and adjunctive use. 
▼
 Total number of individuals in the corresponding age group, not the sum of all instances in the column 
∆
 Due to very low numbers for some substances, the ‘under 12’ and ’12-13’ age groups are combined in this table.  
‡ 
Due to low numbers when breaking down by age, figures for heroin, methadone and other opiates are collapsed into a single opiates category in this table. A 
single young person may therefore be counted as both a primary and adjunctive opiate user, and therefore the sum of primary and adjunctive opiate users 
may be greater than the total number of opiate users. 
* All numbers under  5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest  5 and marked with an asterisk. 
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2.4 Source of referral into treatment (for treatment episodes) 
Table 2.4.1 shows a breakdown of episodes of treatment in the financial year by source 
of referral. Information about source of referral was provided for 17,703 (99.9%) 
episodes of treatment in 2016-17. An individual may have more than one treatment 
episode in the year and all episodes are counted. Therefore, the total number reported 
in this section differs from the total number of young people in treatment in 2016-17.  
 
Education services (29%) continue to be the most common route into specialist 
treatment services, with mainstream education being the single largest source of 
referral (22%). The youth justice system was the second most common referral source 
(25%), although this has been declining as a proportion of referrals in recent years (39% 
in 2010-11). Youth offending teams were the single largest source (21%) within this 
category. 
 
Referrals from social care services went up from 10% of all recorded referrals in 2012-
13 to 15% in 2016-17 (from 2,275 to 2,727). Children and family services referrals 
accounted for 12% in 2016-17 and self-referrals made up 6%. Accident and emergency 
(A&E) referrals account for 1%, while referrals from child and adolescent mental health 
services (CAMHS) account for 4%. Referrals from A&E and CAMHS may be lower than 
expected, based on the available hospital admissions data and evidence about the links 
between young people’s mental health and substance misuse and the use of these 
services by young people8,9,10. 
  
                                            
 
8
 Future in mind, Promoting, protecting and improving our children and young people’s mental health and 
wellbeing, DH, NHS England 2015’ 
 
9
 www.gov.uk/guidance/child-and-maternal-health-data-and-intelligence-a-guide-for-health-professionals 
 
10
 PHE/Royal College of Emergency Medicine Young people’s hospital alcohol pathways: Support pack for 
A&E departments 2014 www.nta.nhs.uk/uploads/young-peoples-hospital-alcohol-pathways-support-pack-for-
ae-departments.pdf 
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Table 2.4.1 Source of referral of all treatment episodes 2016-17 
 
Referral Source n % 
Mainstream education     3,972  22% 
Alternative education      769  4% 
Education service      420  2% 
Other        7  0% 
Education total     5,168  29% 
YOT     3,803  21% 
YP secure estate      182  1% 
Other      373  2% 
Youth / criminal justice total     4,358  25% 
Children and family services     2,095  12% 
Looked after child services      327  2% 
Social services      305  2% 
Social care total     2,727  15% 
Self     1,091  6% 
Relative, family, friend or concerned other      882  5% 
Self, family & friends total     1,973  11% 
Substance misuse total     1,267  7% 
CAMHS      742  4% 
School nurse      324  2% 
A&E      238  1% 
GP      168  1% 
Hospital      112  1% 
Other       69  0% 
Health total     1,653  9% 
YP housing      294  2% 
Other      263  1% 
Total (episodes)    17,703  100% 
Missing or inconsistent data       20    
Total (episodes)    17,723    
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2.5 Education and employment status 
Table 2.5.1 shows the education and employment status at presentation to treatment.  
This was reported for 11,392 (97%) young people who entered treatment in 2016-17.  
 
Of these, over half (56%) were recorded as being in mainstream education (such as 
schools and further education colleges), followed by a further 19% in alternative education 
(such as schooling delivered in a pupil referral unit or home setting). A further 16% were 
recorded as not in employment, education or training (NEET). This profile was broadly 
similar to 2015-16. 
 
Table 2.5.1 Education and employment status of all young people starting  
treatment in 2016-17 
 
Education and employment status n % 
Mainstream education    6,389  56% 
Alternative education    2,199  19% 
Not in employment or education or training (NEET)    1,788  16% 
Apprenticeship or training     432  4% 
Employed     329  3% 
Persistent absentee or excluded     228  2% 
Economically inactive – health issue or caring role      15  0% 
Voluntary work      12  0% 
Total   11,392  100% 
Missing or inconsistent data     361    
Total new presentations   11,753    
 
 
2.6 Accommodation status 
Table 2.6.1 shows the housing situation of 16,169 (98%) young people in treatment in 
2016-17, recorded at treatment entry. 
 
Of these, 13,500 (83%) were recorded as living with their parents or other relatives, while a 
further 3% reported living independently in settled accommodation. Eight per cent (8%) of 
young people stated that they were living in care, with less than 1% living in secure care 
(accommodation within any secure setting where a young person has been placed). This 
profile was broadly similar to 2015-16. 
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Table 2.6.1 Accommodation status of all young people in treatment 2016-17 
 
Accommodation status n % 
Living with parents or other relatives  13,500  83% 
YP living in care   1,292  8% 
YP supported housing     654  4% 
Independent – settled accommodation     467  3% 
Independent – unsettled / housing problem     153  1% 
Independent – no fixed abode      59  0% 
YP living in secure care      44  0% 
Total  16,169  100% 
Missing or inconsistent data     267    
Total  16,436    
 
 
 
2.7 Vulnerabilities 
Young people can enter specialist substance misuse services with a range of problems or 
vulnerabilities relating to their substance use (such as having mental health problems, 
being ‘looked after’ or having a NEET status) or wider factors that can impact on their 
substance use (such as self-harming, sexual exploitation, offending or domestic abuse). 
 
Seventeen vulnerability factors are identified within the NDTMS dataset, the details of 
which are shown in table 2.7.1. These are the range of risk factors that are most likely to be 
associated with problematic substance misuse among young people. 
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Table 2.7.1 Description of vulnerability factors identified via NDTMS 
 
Vulnerability factor Criteria 
Early onset Began using primary substance under the age of 15 
Poly substance user Reported using two or more substances in combination (poly substance 
use) 
 
Antisocial behaviour Young person has been involved in antisocial behaviour or committed a 
criminal act on more than one occasion in the past 6 months (this is the 
offending behaviour disclosed by the individual, not convictions) 
 
Affected by others' 
substance misuse 
Is affected by others’ substance misuse in their close family and/or 
members of the household 
 
Affected by domestic 
abuse 
Has been affected by domestic abuse 
Mental health problem Reported a mental health problem 
Self-harm Reported self-harming behaviour 
NEET Is not in education, employment or training 
Looked after child Has a ’looked after child’ status (see section 7.2) 
Child protection plan The young person is subject to a child protection plan 
Child in need Is a child in need 
Sexual exploitation Reported sexual exploitation 
High-risk alcohol user Drinks almost daily, or in excess of 8 units (males) or 6 units (females) on 
an average drinking day when drinking 13 or more days of the month 
Housing problem Reports unsettled accommodation status or has no fixed abode 
Pregnant and/or parent Is pregnant or a parent 
Opiate and/or crack use Reported using opiates and/or crack among their presenting substances 
Injecting Has ever injected (currently or previously) 
 
Table 2.7.2 shows the number of young people reporting each of the vulnerabilities listed 
above. Vulnerabilities are reported only for new clients entering specialist services during 
the year and therefore the total number reported (11,753) is lower than the total number of 
young people in treatment in 2016-17. An individual young person may report multiple 
vulnerabilities and therefore the percentages in this table may sum to more than 100%. 
 
The most commonly reported vulnerability was early onset of substance misuse, with 84% 
reporting use of their primary substance under the age of 15, followed by 58% reporting 
poly substance use (using more than one substance). Thirty two per cent (32%) reported 
antisocial behaviour, while 23% reported that they were affected by others’ substance 
misuse and 21% reported being affected by domestic abuse. The least commonly reported 
vulnerability was injecting (1%). Females in treatment tend to present to services with a 
different range of vulnerabilities to males. Females are more likely to present with self-harm 
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issues, sexual exploitation (see section 2.8) or domestic abuse, while males are more likely 
to report antisocial behaviour.  
 
There were broadly similar proportions of vulnerabilities reported between 2015-16 and 
2016-17, with the exception of early onset of substance misuse, which fell from 92% to 
84%.  
 
Table 2.7.2 Individual vulnerabilities identified among all young people starting 
treatment in 2016-17 
 
Vulnerability 
Female Male Persons 
n % n % n % 
Early onset of substance misuse   3,386  86%   6,467  83%   9,853  84% 
Poly substance user   2,527  64%   4,290  55%   6,817  58% 
Antisocial behaviour     740  19%   3,009  39%   3,749  32% 
Affected by others' substance misuse   1,110  28%   1,597  20%   2,707  23% 
Affected by domestic abuse   1,093  28%   1,411  18%   2,504  21% 
Mental health problem     947  24%   1,161  15%   2,108  18% 
Self-harm   1,225  31%     719  9%   1,944  17% 
NEET     512  13%   1,357  17%   1,869  16% 
Looked after child     542  14%     858  11%   1,400  12% 
Child Protection Plan     451  11%     477  6%     928  8% 
Child in need     388  10%     469  6%     857  7% 
Sexual exploitation     565  14%     123  2%     688  6% 
High risk alcohol user     230  6%     184  2%     414  4% 
Pregnant and/or parent     104  3%     123  2%     227  2% 
Opiate and/or crack use      92  2%     129  2%     221  2% 
Housing problem      62  2%     106  1%     168  1% 
Injecting      43  1%      51  1%      94  1% 
Total new presentations   3,949  100%   7,804  100%  11,753  100% 
 
A number of young people reported multiple vulnerabilities at treatment start. Individuals 
with substance misuse problems are more likely to experience a wide range of interrelated 
social exclusion problems such as poor health, crime, unemployment and community 
deprivation.11  
 
Table 2.7.3 shows the number of vulnerabilities reported by young people starting 
treatment in 2016-17, with the majority (80%) reporting multiple vulnerabilities. Thirty six per 
cent (36%) reported 4 or more vulnerabilities, with 44% reporting either 2 or 3, 16% 
reported 1, and just 4% reported none.  
 
                                            
 
11
 Neale, J. (2006) Social Exclusion, Drugs and Policy. In R. Hughes, R. Lart & P. Higate (Eds.), 
Drugs, Policy and Politics (pp. 1-17). England: Open University Press. 
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Table 2.7.3 Multiple vulnerabilities reported by young people starting treatment  
in 2016-17 
 
Number of vulnerabilities reported (of total of seventeen) n % 
Zero     436  4% 
One   1,887  16% 
Two   2,884  25% 
Three   2,334  20% 
Four or more   4,212  36% 
Total new presentations  11,753  100% 
 
 
2.8 Sexual exploitation 
Child sexual exploitation (CSE) is a form of child sexual abuse. It occurs where an 
individual or group takes advantage of an imbalance of power to coerce, manipulate or 
deceive a child or young person under the age of 18 into sexual activity (a) in exchange for 
something the victim needs or wants, and/or (b) for the financial advantage or increased 
status of the perpetrator or facilitator. The victim may have been sexually exploited even if 
the sexual activity appears consensual. Child sexual exploitation does not always involve 
physical contact; it can also occur through the use of technology. Department for Education 
have produced guidance around CSE, including this definition, which can be found at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/591903/CSE
_Guidance_Core_Document_13.02.2017.pdf   
 
CSE has important health and wellbeing implications for children and young people and a 
number of reports have highlighted that substance misuse could be an indicator of child 
sexual exploitation and abuse. Young people’s substance misuse services need to ensure 
that they are responding appropriately. PHE has published guidance on how public health 
can support prevention and intervention, which can be found at: 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/629315/PHE
_child_exploitation_report.pdf  
 
Table 2.8.1 shows the breakdown by age and gender of young people who presented to 
treatment services and reported sexual exploitation, compared to all young people newly 
presenting to services in 2016-17. The proportion reporting sexual exploitation is much 
higher among females (14%) than males (2%). Although these figures suggest a large 
difference between sexual exploitation experienced by boys and girls, research from 
Barnardo’s12 has highlighted difficulties in identifying sexual exploitation of boys and young 
                                            
 
12
 Research on the sexual exploitation of boys and young men A UK scoping study Summary of findings August 
2014 Barnardo’s 2014 www.natcen.ac.uk/media/530798/16134-su-cse-young-boys-summary-report-v3.pdf  
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men because they often do not disclose abuse. The median age of young people reporting 
sexual exploitation was 15, the same as for all new presentations. 
 
Table 2.8.1 Age and gender breakdown of young people starting treatment in 2016-17 
and reported sexual exploitation 
 
Age 
Sexual exploitation Total new presentations 
Female Male Female Male 
n % n % n % n % 
Under 14∆ 66 12% 16 13% 413 10% 683 9% 
14-15 116 21% 21 17% 782 20% 1,201 15% 
15-16 156 28% 26 21% 1,094 28% 2,081 27% 
16-17 120 21% 37 30% 826 21% 1,853 24% 
17-18 107 19% 23 19% 834 21% 1,986 25% 
Total new 
presentations 
565 100% 123 100% 3,949 100% 7,804 100% 
 
∆
 Due to low numbers when breaking down by age and gender, age groups under 14 are combined in this table. 
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3. Access to services 
3.1 Waiting times for first and subsequent treatment interventions 
The table below shows a breakdown of waiting times under and over 3 weeks by first and 
subsequent interventions (that is where a client who is already receiving an intervention is 
referred to start another type of treatment). Of the 17,445 first interventions beginning in 
2016-17, 17,050 (98%) had waiting times of 3 weeks or under, with 81% of first 
interventions starting on the same day as referral. There were 696 subsequent 
interventions, of which 671 (96%) waited no more than 3 weeks. Overall the average 
(mean) wait to commence treatment (first interventions only) was two days. 
 
Table 3.1.1 Waiting times: first and subsequent interventions 2016-17 
 
Intervention 
3 weeks or under Over 3 weeks Total 
n % n % n % 
First Intervention     17,050  98%        395  2%     17,445  100% 
Subsequent Intervention        671  96%         25  4%        696  100% 
Total Interventions     17,721  98%        420  2%     18,141  100% 
 
 
3.2 Treatment interventions 
As part of a young person’s treatment package, an individual may receive more than one 
intervention (more than one type of treatment) while being treated at a service and may 
attend more than 1 service for subsequent interventions. For example, the young person 
might receive a 1 to 1 intervention such as motivational interviewing in addition to a family 
intervention.  
 
From 1 November 2013, the way interventions were recorded on NDTMS was changed to 
include 3 high-level structured intervention types (psychosocial, harm reduction and 
pharmacological) and an intervention setting. 
 
Tables 3.2.1 and 3.2.2 show the breakdown of intervention types received by young people 
in contact with structured treatment. The vast majority of young people (15,012, 93%) 
received psychosocial intervention(s). Psychosocial interventions (sometimes known as 
‘talking therapies’) use psychological, psychotherapeutic and counselling skills to 
encourage change. Many young people received harm reduction interventions (9,846, 
61%), with 8,627 (52%) receiving both psychosocial and harm reduction interventions only. 
Structured harm reduction includes support to manage risky behaviour associated with 
substance misuse, overdose and accidental injury through substance misuse. Seventy-nine 
(79) young people received a pharmacological intervention (0.5%). Pharmacological  
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interventions for young people cover a wide range of medication prescribed by a clinician, 
and may involve detoxification, stabilisation, symptomatic relief from substance misuse and 
relapse prevention, as well as substitute prescribing for opiate and alcohol misuse. 
 
Table 3.2.1 shows the number of clients who received a pre-November 2013 dataset 
change intervention that cannot be mapped directly to the current method of recording (see 
section 6.2 for more detail on this change). Individuals are counted once for each 
intervention type they received. 
 
Table 3.2.1 Interventions received by young people in treatment in 2016-17  
(pre-November 2013 dataset change interventions) 
 
Intervention n 
Inpatient detoxification  *  
Other YP intervention            45  
 
* All numbers under  5 have been suppressed. Where totals could be derived, figures have been rounded to the 
nearest  5 and marked with an asterisk. 
 
Table 3.2.2 provides information on interventions commenced after the changes to the core 
dataset on 1 November 2013. It shows the number of young people who received 
interventions based on the post November 2013 intervention codes and intervention 
settings. If an individual’s intervention features in table 3.2.2, and can be directly mapped 
between tables, it is not featured in table 3.2.1 above to avoid double counting.  
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Table 3.2.2 Interventions received by young people in treatment 2016-17 (post November 2013 dataset change interventions) 
 
Setting 
Intervention type 
Total 
individuals with 
this settingΔ 
Percentage of total 
individuals with 
this setting 
Psychosocial 
(n) 
Harm 
reduction 
(n) 
Pharmacological 
(n) 
Community 14,541 9,533 67 15,710 97% 
Home 542 335 8 594 4% 
YP Residential unit 14 10 0 16 0% 
Adult setting 12 * 6 14 0% 
YP Inpatient unit 6 * 0 8 0% 
No setting recorded 0 0 0 0 - 
Total individuals‡ 15,012 9,846 79 16,189 100% 
% of total individuals with this intervention 93% 61% 0.5%     
 
‡ 
This is the total number of individuals receiving each type of intervention and not a summation of values within the column. 
∆ 
This is the total number of individuals receiving at least one type of intervention in each setting and not a row total. 
* All numbers under  5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest  5 and marked with an asterisk
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3.3 Length of latest treatment episode 
The majority of young people’s most recent episodes were 26 weeks or less in duration 
(74%). The average (mean) time of an individual’s most recent episode of treatment during 
2016-17 was around 5 months (151 days). 
 
Table 3.3.1 Length of latest episode 2016-17 
 
Episode Length n % 
0 (zero) to 12 weeks 6,928 43% 
13 to 26 weeks 5,000 31% 
27 to 52 weeks 3,122 19% 
Longer than 52 weeks 1,150 7% 
Total 16,200 100% 
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4. Treatment exits 
4.1 Treatment exits 
Table 4.1.1 and figure 4.1.1 report on the treatment exit reasons for young people exiting in 
2016-17. There were 10,834 treatment exits in 2016-17, representing 66% of the 16,436 
young people in treatment in the year. The remaining 5,602 young people (34%) were 
retained in treatment on 31 March 2017. Among those who exited treatment, 8,842 (82%) 
did so after completing specialist treatment in a planned way.  
 
Table 4.1.1 Treatment exit reasons of all young people exiting treatment 2016-17 
 
Treatment exit reason n % 
Completed     8,842  82% 
Dropped out / left     1,178  11% 
Referred on      469  4% 
Treatment declined by client      197  2% 
Other      105  1% 
Prison       43  0% 
Total    10,834  100% 
 
Figure 4.1.1 Treatment exit reasons of all young people exiting treatment 2016-17 
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5. Trends over time 
5.1 Trends in age and numbers in treatment 
The number of young people attending specialist substance misuse services during 2016-
17 was 16,436, a decrease of 641 (4%) from 17,077 in 2015-16, and a reduction of 7,617 
(32%) since the peak of 24,053 in 2008-09. General decreasing trends in alcohol and drug 
use among young people in the last decade may in part explain this decline, although it is 
also possible that any reduction in the provision of youth support services may affect the 
number of referrals into specialist services. Although there has been a general decrease in 
the number of young people under 14 in treatment over time, the proportion aged under 14 
(out of all young people in treatment) has remained fairly stable, and there was a small 
increase in the number aged under 14 in 2016-17. Any substance misuse among this age 
group is concerning and they are likely to be at risk of harm. In these cases, safeguarding 
needs to be a priority, with every aspect of the child’s life addressed, not just the substance 
misuse.   
 
Table 5.1.1 Number of young people in treatment by age (2005-06 to 2016-17) 
 
Age 
2005-06 2006-07 2007-08 2008-09 
n % n % n % n % 
Under 12 212 1% 233 1% 227 1% 193 1% 
12-13 358 2% 457 2% 467 2% 442 2% 
13-14 1,040 6% 1,253 6% 1,476 6% 1,500* 6% 
14-15 2,380 14% 2,961 14% 3,466 14% 3,550* 15% 
15-16 3,884 23% 4,953 23% 5,658 24% 5,574 23% 
16-17 4,347 26% 5,315 25% 5,987 25% 6,133 25% 
17-18 4,780 28% 6,019 28% 6,624 28% 6,663 28% 
Total 17,001 100% 21,191 100% 23,905 100% 24,053 100% 
 
Age 
2009-10 2010-11 2011-12 2012-13 
n % n % n % n % 
Under 12 155* 1% 128 1% 110 1% 56 0% 
12-13 380* 2% 315 1% 323 2% 310 2% 
13-14 1,396 6% 1,234 6% 1,129 5% 1,130 6% 
14-15 3,300* 14% 3,092 14% 3,009 15% 2,936 15% 
15-16 5,770 25% 5,445 25% 5,097 25% 5,097 25% 
16-17 5,823 25% 5,657 26% 5,297 26% 5,040 25% 
17-18 6,701 28% 6,084 28% 5,723 28% 5,463 27% 
Total 23,528 100% 21,955 100% 20,688 100% 20,032 100% 
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Age 
2013-14 2014-15 2015-16 2016-17 
n % n % n % n % 
Under 12 46 0% 43 0% 48 0% 68 0% 
12-13 227 1% 225 1% 211 1% 284 2% 
13-14 1,008 5% 951 5% 909 5% 990 6% 
14-15 2,785 15% 2,643 14% 2,624 15% 2,610 16% 
15-16 4,922 26% 4,862 26% 4,476 26% 4,346 26% 
16-17 5,092 27% 4,866 27% 4,472 26% 4,109 25% 
17-18 5,046 26% 4,759 26% 4,337 25% 4,029 25% 
Total 19,126 100% 18,349 100% 17,077 100% 16,436 100% 
 
 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to  
the nearest 5 and marked with an asterisk. 
 
5.2 Trends in primary substance 
Figure 5.2.1 shows the number of young people in treatment in each given year and the 
primary problematic substance recorded when they presented to treatment.  
 
Since 2005-06, young people have been increasingly likely to seek help for problems with 
cannabis compared to other substances. During 2016-17, 12,712 presented to specialist 
services with cannabis as their primary substance (77% of all those receiving help during 
the year). The number of primary cannabis presentations has decreased by 7% since 
2013-14 (from 13,659 to 12,712), but this has continued to increase as a proportion of all 
young people in treatment (up 6% from 71% in 2013-14).  
 
Findings from the 2016-17 Crime Survey for England and Wales show that cannabis use 
and prevalence peak in the late teens/early 20s13. 
 
The number of young people citing alcohol as a primary substance has decreased slightly 
from 2,556 in 2015-16 to 2,465 in 2016-17, although the proportion of the total population 
has remained similar (15% of all those receiving help in each year). This is, however, 
significantly lower than the 2008-09 peak of 8,799 (37% of the total population). The 
number of primary alcohol presentations has decreased consecutively each year since 
2008-09. 
 
 
 
 
                                            
 
13
 Drug misuse: findings from the 2016/17 Crime Survey for England and Wales. Home Office 2017 
https://www.gov.uk/government/statistics/drug-misuse-findings-from-the-2016-to-2017-csew 
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Table 5.2.1 shows that the number in treatment for primary amphetamine use has fallen in 
the last 4 years. Numbers of young people in treatment for opiates and crack cocaine have 
fallen markedly over the last ten years and now represent 0.6% and 0.1% respectively of 
the young treatment population compared to 5.3% and 1.2% respectively in 2005-06. 
Section 5.3 explores trends in drug use other than cannabis and alcohol in more detail, 
including adjunctive use.  
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Figure 5.2.1 Number of young people in treatment by primary substance (2005-06 to 2016-17) 
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Table 5.2.1 Number of young people in treatment by primary substance  
(2005-06 to 2016-17) 
 
Substance 
2005-06 2006-07 2007-08 2008-09 
n % n % n % n % 
Opiates 881 5% 755 4% 651 3% 547 2% 
Amphetamines 332 2% 323 2% 346 1% 230* 1% 
Cocaine 453 3% 655 3% 806 3% 745* 3% 
Crack 200 1% 137 1% 155 1% 110 0% 
Ecstasy 325 2% 432 2% 438 2% 210* 1% 
Cannabis 9,043 55% 10,824 52% 12,021 51% 12,642 53% 
Solvents 210 1% 301 1% 305 1% 284 1% 
Alcohol 4,886 30% 7,039 34% 8,589 36% 8,799 37% 
NPS  -   -   -   -   -   -   -   -  
Other‡ 174 1% 183 1% 241 1% 270* 1% 
 
Substance 
2009-10 2010-11 2011-12 2012-13 
n % n % n % n % 
Opiates 480* 2% 320* 1% 211 1% 175* 1% 
Amphetamines 256 1% 639 3% 493 2% 755* 4% 
Cocaine 457 2% 350* 2% 301 1% 245* 1% 
Crack 50* 0% 35* 0% 40 0% 27 0% 
Ecstasy 90* 0% 65* 0% 79 0% 130* 1% 
Cannabis 13,123 56% 12,784 58% 13,200 64% 13,581 68% 
Solvents 274 1% 263 1% 236 1% 163 1% 
Alcohol 8,227 35% 7,054 32% 5,884 29% 4,704 24% 
NPS  -   -   -   -   -   -   -   -  
Other‡ 399 2% 349 2% 189 1% 210* 1% 
 
Substance 
2013-14 2014-15 2015-16 2016-17 
n % n % n % n % 
Opiates 160* 1% 134 1% 112 1% 94 1% 
Amphetamines 591 3% 540* 3% 317 2% 71 0% 
Cocaine 254 1% 250* 1% 251 1% 254 2% 
Crack 14 0% 24 0% 21 0% 16 0% 
Ecstasy 124 1% 165* 1% 261 2% 340 2% 
Cannabis 13,659 71% 13,454 73% 12,863 75% 12,712 77% 
Solvents 134 1% 135 1% 121 1% 128 1% 
Alcohol 3,776 20% 3,133 17% 2,556 15% 2,465 15% 
NPS 120* 1% 334 2% 420 2% 213 1% 
Other‡ 271 1% 165* 1% 148 1% 133 1% 
 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the 
nearest 5 and marked with an asterisk. 
 
‡
 From 2014-15, codes relating to prescribed opiates have been moved from the ‘Other’ category to ‘Opiates’. This 
affects a very small number of young people and the change has not been backdated.  
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5.3 Trends in other drug use (not cannabis or alcohol)  
Figure 5.3.1 shows the number of young people in treatment in each year from 2007-08 to 
2016-17, where the individual has cited drug use other than cannabis and alcohol. These 
substances are often adjunctive to cannabis or alcohol and are less frequently cited as the 
main substance young people seek treatment for. Due to low numbers, the figures for 
primary and adjunctive use are combined, and the 5 most commonly cited substances are 
reported on, as well as opiates. Figures are reported from 2007-08 as this was the earliest 
year in which adjunctive drug use was reported as part of these statistics. 
 
Ecstasy was the most commonly cited substance after cannabis and alcohol in 2016-17 
(1,815, or 11% of young people), followed by cocaine (1,473, or 9% of young people). The 
number of young people in treatment who had cited problematic ecstasy use increased by 
13% from 1,605 in 2015-16 to 1,815 in 2016-17. This was below the peak of 2,281 in 2007-
08, but 148% higher than in 2011-12, when 732 young people in treatment said they had 
problems with ecstasy. The number of young people in treatment for problematic cocaine 
use has been similar from 2012-13 onwards.  
 
New psychoactive substances or NPS are chemical substances that produce similar effects 
to ‘established’ drugs (like cocaine, cannabis and ecstasy). Originally created to side-step 
legislation, an increasing number are controlled under the Misuse of Drugs Act 1971, but all 
remaining are now covered by the Psychoactive Substances Act 2016. Data on NPS use is 
reported here for the fourth year using a series of new drug codes describing NPS 
according to their predominant effect. The full breakdown of young people in treatment 
citing other drug use, including NPS use is shown in table 5.3.1. 
 
The number of young people reporting problems with NPS reduced by 45% compared to 
2015-16, from 1,056 to 585 in 2016-17. The numbers are lower compared to ecstasy 
(1,815) and cocaine (1,477) use. However, specialist substance misuse services need to 
ensure that they continue to be accessible and relevant to those young people who may 
require support for NPS problems, in particular those young people who may be most 
vulnerable to developing problems with these drugs, such as young people with mental 
health problems, special needs and homeless young people.  
 
The number of young people citing amphetamine use decreased by 57% between 2015-16 
and 2016-17 to 491 individuals. Solvent use also continued to decrease slightly, from 441 
in 2015-16 to 430 in 2016-17 (2.5% reduction compared to last year). 
 
Opiate use among young people in treatment has been decreasing since 2007-08, with 181 
young people receiving help for their problematic opiate use in 2016-17, compared to 889 
young people 10 years ago. 
Young people’s statistics from NDTMS 
 
 
39 
 
Figure 5.3.1 Number of young people in treatment for other drug use, excluding cannabis and alcohol  
(2007-08 to 2016-17) 
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Table 5.3.1 Trends in numbers in treatment for other drug use, excluding cannabis and alcohol 2007-08 to 2016-17^ 
 
Substance 2007-08 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 
Ecstasy 2,281 1,644 1,183 746 732 997 1,084 1,338 1,605 1,815 
Cocaine 2,852 3,050 2,386 1,890* 1,630* 1,435* 1,499* 1,432 1,477 1,473 
NPS (any) ‡  - -   -  -  -  - 324 887 1,056 585 
NPS - Predominantly stimulant ‡  -  -  -  -  -  - 60 154 121 50 
NPS - Predominantly hallucinogenic ‡  -  -  -  -  -  - 29 46 37 18 
NPS - Predominantly dissociative ‡  -  -  -  -  -  - * 5 32 20 
NPS - Predominantly sedative/opioid ‡  -  -  -  -  -  - * 9 13 * 
NPS - Predominantly cannabinoid ‡  -  -  -  -  -  - 203 557 695 407 
NPS – other ‡  -  -  -  -  -  - 39 139 175 91 
Amphetamines 1,259 1,116 1,063 1,977 1,836 2,280* 1,961* 1,740* 1,152 491 
Solvents  310* 562 559* 503 451 338* 294* 357 441 430 
Opiates 889 751 670 479 326 285 265 220 206 181 
 
^ Primary and adjunctive use are combined in this table, therefore a young person may be counted for more than once in this table. 
* All numbers under  5 have been suppressed. Where totals could be derived, figures have been rounded to the nearest  5 and marked with an asterisk. 
‡
 Codes for NPS were added to the NDTMS core data set in 2013-14. Any individuals reporting NPS prior to this are counted in the ‘Any club drug cited’ total 
but no separate totals are given for NPS. An individual may report more than one NPS drug and therefore the sum of individual NPS drugs may exceed the 
total reported for NPS (any). 
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5.4 Trends in treatment exit reasons 
Table 5.4.1 reports treatment exit reasons for clients in the years 2005-06 to 2016-17. In 
2009, a new discharge coding system was introduced that tightened the way ‘treatment 
completed’ was recorded. These changes mean it is not possible to directly compare 
treatment exit data from 2009-10 onwards with previous years. For further details, see:  
http://www.ndtms.net/resources/secure/Quality-and-Methodology-NDTMS-2016-17.pdf.  
 
Treatment completions, as a proportion of exits, have increased annually over this period, 
from 69% in 2009-10 to 82% in 2016-17. Those being transferred for further structured drug 
and/or alcohol treatment fell to 4% from 6% in 2015-16, the lowest proportion since the new 
coding system was introduced. 
 
Table 5.4.1 Trends in treatment exit reasons (2005-06 to 2016-17) 
  
Treatment exit reason 
2005-06 2006-07 2007-08 2008-09 
n % n % n % n % 
Complete 4,105 48% 5,726 50% 8,073 57% 9,546 65% 
Referred on 572 7% 701 6% 938 7% 510 3% 
Dropped out / left 2,525 29% 2,902 25% 2,529 18% 2,253 15% 
Prison 200 2% 285 2% 339 2% 371 3% 
Treatment declined by client * 0% 246 2% 703 5% 620* 4% 
Not known 102 1% 202 2% 98 1% 71 0% 
Other 1,108 13% 1,448 13% 1,401 10% 1,250 9% 
Total 8,615* 100% 11,510 100% 14,081 100% 14,620* 100% 
 
 
Treatment exit reason 
2009-10 2010-11 2011-12 2012-13 
n % n % n % n % 
Complete 10,160 69% 10,507 75% 10,118 77% 10,208 79% 
Referred on 856 6% 793 6% 841 6% 760 6% 
Dropped out / left 2,408 16% 1,851 13% 1,630 12% 1,530 12% 
Prison 183 1% 139 1% 97 1% 66 1% 
Treatment declined by client 529 4% 440 3% 326 2% 278 2% 
Not known 51 0% 16 0% 0 0% 0 0% 
Other 478 3% 260 2% 175 1% 105 1% 
Total 14,665 100% 14,006 100% 13,187 100% 12,947 100% 
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Treatment exit reason 
2013-14 2014-15 2015-16 2016-17 
n % n % n % n % 
Complete 9,852 79% 9,613 80% 8,929 80% 8,842 82% 
Referred on 852 7% 773 6% 722 6% 469 4% 
Dropped out / left 1,440 12% 1,345 11% 1,237 11% 1,178 11% 
Prison 62 0% 52 0% 31 0% 43 0% 
Treatment declined by client 244 2% 236 2% 245 2% 197 2% 
Not known 0 0% 0 0% 0 0% 0 0% 
Other 60 0% 55 0% 60 1% 105 1% 
Total 12,510 100% 12,074 100% 11,224 100% 10,834 100% 
 
* All numbers under 5 have been suppressed. Where totals could be derived, figures have been rounded to the 
nearest 5 and marked with an asterisk. 
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6. History 
This report presents information relating to drug and alcohol treatment in England. The 
statistics are derived from data that has been collected through NDTMS. NDTMS collects 
activity data from substance misuse treatment services so that: 
 
 the progress of individuals entering treatment may be monitored and their outcomes 
assessed  
 trends and shifts in patterns of drug and alcohol use can be monitored, to inform 
future planning locally and nationally  
 the impact of substance misuse treatment as a component of the wider public health 
service may be measured 
 treatment services can demonstrate their accountability to young people, parents and 
carers, local commissioners and communities  
 costs can be benchmarked against data from comparable areas to show how 
efficiently they use resources and how they are delivering value for money 
 
Drug treatment activity has been collected nationally for nearly 25 years and has been 
routinely collected through NDTMS since April 2004. NDTMS is currently managed by PHE. 
  
NDTMS has been reorganised over the years, bringing the definition of drug treatment 
recorded by the system further into line with ‘Models of care for treatment of adult drug 
users’: www.nta.nhs.uk/publications/documents/nta_modelsofcare_update_2006_moc3.pdf 
  
Since 2003-04 data collection has been consistently collected by treatment services, 
submitting a core data set of their clients’ information as a database extract. The dataset 
and data collection methods have also changed. Code sets for the core data set can be 
found in NDTMS reference data document: 
www.nta.nhs.uk/areas/ndtms/core_data_set_page.aspx 
  
NDTMS figures for England are collated by The National Drug Evidence Centre (NDEC), 
along with those for Scotland, Wales and Northern Ireland, and combined into a UK return 
for use by the European Monitoring Centre for Drugs and Drug Addiction, and for the 
United Nations: www.emcdda.europa.eu/html.cfm/index190EN.html 
  
This statistical release covers England only. Information on drug treatment in Wales, 
Scotland and Northern Ireland is also available: 
www.wales.gov.uk/keypubstatisticsforwales/topicindex/topics.htm#public (Wales) 
www.scotpho.org.uk/comparative-health/profiles/online-profiles-tool (Scotland) 
www.dhsspsni.gov.uk/articles/drugs-statistics (Northern Ireland) 
  
NDEC is part of the Centre for Epidemiology, which is one of 6 centres in the Institute of 
Population Health, Health Services Research & Primary Care, University of Manchester.  
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While comparisons to alcohol treatment statistics from other countries can be made, care 
needs to be taken as the data is unlikely to be directly comparable due to differences in the 
definitions and methodologies that are used in collecting the data and in subsequently 
reporting it.  
 
6.1 Relevant web links and contact details 
Monthly web-based NDTMS analyses 
www.ndtms.net/ 
Public Health Outcomes Framework indicators 2.15i, 2.15ii, 2.15iii and 2.15iv  
http://www.phoutcomes.info/public-health-outcomes-framework 
National Drug Evidence Centre (NDEC) 
www.medicine.manchester.ac.uk/healthmethodology/research/ndec/ 
Public Health England 
www.gov.uk/government/organisations/public-health-england 
 
General enquiries 
For media enquiries, call 020 3682 0574 or email phe-pressoffice@phe.gov.uk 
For technical enquiries, email EvidenceApplicationteam@phe.gov.uk 
 
Policy 
Evidence application team, PHE 
EvidenceApplicationteam@phe.gov.uk 
 
Data and statistics 
Martin White, programme manager, PHE 
Martin.White@phe.gov.uk 
Solina Li, senior information analyst, PHE 
Solina.Li@phe.gov.uk 
Andrew Jones, senior research fellow, NDEC 
Andrew.Jones@manchester.ac.uk 
Stefan Jahr, senior information analyst, NDEC 
Stefan.Jahr@manchester.ac.uk 
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6.2 Comparability of data to previous reports 
Since 1 November 2013, PHE made substantial changes to the core dataset with regards 
to young people and the coding of intervention type. Prior to this, intervention codes were 
restricted to 8 categories:  
 
 harm reduction 
 pharmacological 
 psychosocial (counselling) 
 psychosocial (cognitive behaviour therapy) 
 psychosocial (motivational interviewing 
 psychosocial (relapse prevention) 
 psychosocial (family work) 
 the setting where the interventions were being delivered was not recorded 
 
Following consultations with clinicians, treatment providers and other key stakeholders, 
a new method of recording interventions types and setting was introduced alongside the 
ability for providers to record the non-structured multi-agency working interventions that 
they were delivering. These changes enable a better understanding of the different 
interventions being provided nationally and in local areas, which will in turn benefit 
commissioning and service planning as well as influencing national policy setting.  
From 1 November 2013, all registered young people’s treatment providers are registered 
with one of 7 setting types:  
 
 community 
 home 
 secure estate 
 in-patient (substance misuse specific) 
 in-patient (not substance misuse specific) 
 residential (substance misuse specific) 
 residential (not substance misuse specific), which have now been incorporated to 
PHE’s regular reporting  
 
Clients in secure estate settings are not reported on in this document. Definitions of 
these settings can be found in section 7.2 and the business definitions guide at 
http://www.nta.nhs.uk/uploads/yp-treatment-business-definition-v11.06-wn-
comments.pdf. Intervention types have been split in to 4 high-level categories:  
 
 pharmacological interventions 
 psychosocial interventions 
 harm reduction interventions 
 multi-agency working interventions.  
 
Multi agency working interventions are not reported on in the present report.  
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Other changes to the core dataset with regards to young people also occurred in the 
dataset change on 1 November 2013. Valid responses to accommodation status and 
education and employment status were changed at this time. For more details please see 
the latest business definitions at http://www.nta.nhs.uk/uploads/yp-treatment-business-
definition-v11.06-wn-comments.pdf. 
The final change following the consultations with clinicians, treatment providers and other 
key stakeholders was to introduce a new set of questions to capture vulnerabilities, risk and 
resilience factors at the start of treatment. 
 
6.3 Drug treatment collection and reporting timeline 
1989 to March 2001 Regional Drug Misuse Database (RDMD) – statistics reported in 6 
monthly bulletins by DH from 1993 to 2001: 
webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/en/Publications
andstatistics/Statistics/StatisticalWorkAreas/Statisticalpublichealth/DH_4015620  
April 2001 to March 2004 NDTMS - statistics reported annually by the Department of Health 
(DH) 
April 2004 to March 2013 NDTMS - managed by the National Treatment Agency (NTA) 
reporting statistics annually up to March 2012. 
April 2013 to date NDTMS - managed by Public Health England (PHE) reporting statistics 
annually from April 2012. 
 
6.4 Other sources of statistics about drugs and alcohol 
6.4.1 Prevalence of substance use  
Information is available relating to the prevalence of drug use among secondary school 
pupils aged 11 to 15 from the Smoking, Drinking and Drug Use Survey among young 
people in England. This is a survey carried out for the NHS Information Centre by the 
National Centre for Social Research and the National Foundation for Educational 
Research. The survey interviews school pupils, and has been in place since 2001. It 
reported annually up to 2014-15 and the latest report for 2016-17 was published on 2 
November 2017. The data and further information are available at: 
https://digital.nhs.uk/catalogue/PUB30132 
Findings from a survey called ‘What About YOUth’ were published in December 2015. It 
asked 15-year olds about a range of subjects including what they eat, what they do in their 
free time, bullying and whether they smoke, drink alcohol or have taken drugs. Local level 
data on drug and alcohol use is available at: www.whataboutyouth.com/  
NDTMS collects data on drug and alcohol treatment for young people, and produces official 
statistics bulletins, which can be found at: www.nta.nhs.uk/statistics.aspx. 
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An annual estimate of the prevalence of drug use is undertaken through the Crime Survey 
for England and Wales (CSEW; formerly the British Crime Survey). This section of the 
survey has been in place since 1996, annually since 2001, and has tracked the prevalence 
of the use of different drugs over this time. This does not include information on all young 
people but does show the data for the age group 16 to 24. 
https://www.gov.uk/government/statistics/drug-misuse-findings-from-the-2016-to-2017-
csew 
 
A second method is used to produce estimates for the prevalence of opiate and/or crack 
cocaine use for people aged 15-64 (with estimates broken down by age group, the youngest 
being 15 to 24) each local authority area in England. Estimates are available for 2004-05, 2005-
06, 2006-07, 2008-09, 2009-10, 2010-11, 2011-12 and 2014-15. 
 
The estimates are produced through a mixture of capture-recapture and Multiple Indicator 
Methodology (MIM), and rely on NDTMS (community and prison) data being matched against 
and/or analysed alongside Probation and Home Office data sets. The data and further 
information are available at: www.nta.nhs.uk/facts-prevalence.aspx. 
 
6.4.2 Youth justice statistics 
The Ministry of Justice and the Youth Justice Board for England and Wales publish annual 
statistics that detail the number of young people (aged 10 to 17) arrested, along with 
proven offences, criminal history, characteristics of young people, the number sentenced, 
those on remand, those in custody, re-offending and behaviour management: 
www.gov.uk/government/collections/youth-justice-annual-statistics 
 
In addition, NDTMS collects data on drug and alcohol treatment in secure settings and will 
produce the next set of official statistics for 2016-17 on 18 January 2018. This will include 
information on young people accessing treatment in secure settings. The report will be 
available at: www.nta.nhs.uk/statistics.aspx. 
 
6.4.3 International comparisons 
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) publishes an 
annual report that describes and compares aspects of drug use and drug policy within 
European states, as well as providing detailed comparative statistics. This can be found at: 
http://www.emcdda.europa.eu/edr2017. 
 
The centre also produces a treatment demand indicator (TDI), which is a collection of 
comparative statistics relating to individuals seeking treatment. This can be found at 
www.emcdda.europa.eu/data/stats2017#displayTable:TDI-0023. 
 
While comparisons to alcohol treatment statistics from other countries can be made, care 
needs to be taken as the data is unlikely to be directly comparable due to differences in the 
Young people’s statistics from NDTMS 
 
 
48 
definitions and methodologies that are used in collecting the data and subsequently in 
reporting it. 
 
6.4.4 Adult drug and alcohol treatment 
PHE also publishes annual reports regarding adults accessing drug and alcohol treatment. 
These can be found at www.nta.nhs.uk/statistics.aspx 
 
Note that young people’s figures are not comparable with statistics relating to adult drug or 
alcohol treatment. This is because access to specialist services for young people requires a 
‘lower severity of drug use and associated problems’.14 
 
6.4.5 Drug-related deaths 
The Office for National Statistics publishes an annual summary of all deaths related to drug 
poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal drugs) in 
England and Wales. This covers all ages with young people forming part of the ‘under 20’ 
age group and can be found at: 
https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/
bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2016registrations. 
  
  
                                            
 
14
 Drug Misuse and Dependence – UK Guidelines on Clinical Management, p.85, London: Department of Health 
(England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive. 
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7. Abbreviations and definitions 
7.1 Abbreviations 
A&E Accident and emergency department 
CAMHS Child and adolescent mental health services  
ChiMat Child and Maternal Health Intelligence Network  
CSE Child sexual exploitation 
CSEW Crime Survey for England and Wales 
DfE Department for Education 
DH Department of Health 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
GP General practitioners 
HBSC Health Behaviour in School-aged Children 
MIM Multiple Indicator Methodology 
NDEC National Drug Evidence Centre  
NDTMS National Drug Treatment Monitoring System 
NEET Not in education, employment or training 
NO Nitrous oxide 
NPS New psychoactive substances 
NTA National Treatment Agency for Substance Misuse 
ONS Office for National Statistics 
PHE Public Health England 
TDI Treatment Demand Indicator 
YOT Youth offending team 
YP Young people 
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7.2 Definitions 
Adjunctive drug use Substances additional to the primary substance used by the 
individual, NDTMS collects secondary and tertiary substances. 
Agency /provider A provider of services for the treatment of substance misuse. 
They may be statutory (i.e. the NHS) or non-statutory (i.e. third 
sector, charitable). 
Attributor A concatenation of a client’s initials, date of birth and gender. 
This is used to isolate records that relate to individual clients. 
Client A drug or alcohol user presenting for treatment at a structured 
treatment service. Records relating to individual clients are 
isolated and linked based on the attributor. 
Community setting A young person’s drug and alcohol service where residence is 
not a condition of engagement with that service. This will 
include all providers delivering interventions in a non-residential 
setting.  
Discharge date This is usually the planned discharge date in a client’s 
treatment plan, where one has been agreed. However, if a 
client's discharge was unplanned, then the date of last face-to-
face contact with the provider (agency) is used. 
 
Drug-related death / 
drug misuse death 
Annual figures published by the Office for National Statistics 
(ONS) since 1993 cover deaths in England and Wales related 
to “drug poisoning (involving both legal and illegal drugs)” and 
to “drug misuse (involving illegal drugs)”. 
 
The ONS's definition of a drug misuse death is “(a) deaths 
where the underlying cause is drug abuse or drug dependence 
and (b) deaths where the underlying cause is drug poisoning 
and where any of the substances controlled under the Misuse 
of Drugs Act 1971 are involved". 
 
Where people do suffer drug poisonings while in treatment, 
these are overwhelmingly classed as drug misuse, so this 
definition may be seen as more relevant to this population. 
However, many of those who die in treatment are not included 
under either definition as they die from causes other than 
poisoning. 
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Episode A period of contact with a treatment provider (agency): from 
referral to discharge. 
Episode of treatment A set of interventions with a specific care plan. A client may 
attend one or more interventions (or types) of treatment during 
the same episode of treatment. A client may also have more 
than one episode in a year. A client is considered to have been 
in contact during the year, and hence included in these results, 
if any part of an episode occurs within the year. Where several 
episodes were collected for an individual, attributes such as 
ethnicity, primary substance, etc. are based on the first valid 
data available for that individual. 
 
Family work 
intervention 
Interventions using psychosocial methods to support parents, 
carers and other family members to manage the impact of a 
young person’s substance misuse and enable them to better 
support the young person in their family. 
First/subsequent 
intervention 
First intervention' refers to the first intervention that occurs in a 
treatment journey. 'Subsequent intervention' refers to 
interventions, within a treatment journey, that occur after the 
first intervention. 
Home setting The young person is being supported with specialist substance 
misuse interventions in his/her home by the treatment provider. 
In contact Clients are counted as being in contact with treatment services 
if their date of presentation (as indicated by triage/initial 
assessment), intervention start, intervention end or discharge 
indicates that they have been in contact with a provider during 
the year. 
 
Inpatient unit (not 
substance misuse 
specific) setting 
An inpatient unit provides assessment, stabilisation and/or 
assisted withdrawal with 24-hour cover. Such as a hospital unit.  
Inpatient unit 
(substance misuse 
specific) setting 
An inpatient unit provides assessment, stabilisation and/or 
assisted withdrawal with 24-hour cover from a multi-disciplinary 
team who have had specialist training in managing addictive 
behaviours. Such as paediatric ward, adult ward, child and 
adolescent mental health ward, etc.  
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Intervention A type of treatment, e.g. structured counselling, community 
prescribing, etc. 
Looked after child The definition of a looked after child (from the Children Act 
198915) is “Children looked after includes all children being 
looked after by a local authority including those subject to care 
orders under section 31 of the Children Act 1989 and those 
looked after on a voluntary basis through an agreement with 
their parents under section 20 of the Children Act 1989”. 
New psychoactive 
substance (NPS) 
Chemical substances that produce similar effects to 
‘established’ drugs (like cocaine, cannabis and ecstasy). 
Originally created to side-step legislation, an increasing number 
are controlled under the Misuse of Drugs Act 1971 but all 
remaining are now covered by the Psychoactive Substances 
Act 2016.  
Opiate A group of drugs including heroin, methadone and 
buprenorphine that act on opioid receptors. 
Pharmacological 
intervention 
Interventions that include prescribing for detoxification, 
stabilisation and symptomatic relief of substance misuse as well 
as prescribing to prevent relapse. For young people this 
intervention includes a wide range of medication prescribed by 
a clinician, not solely substitute prescribing for opiate addiction. 
Planned discharge A treatment exit where the discharge reason is 'treatment 
completed'. This includes ‘Treatment 
completed – Drug free’ and ‘Treatment Completed - Occasional 
user’ from the current core data set. It also 
includes any codes from previous datasets that begin with 
‘Treatment completed’ or ‘completed’. 
Poly drug use The reporting of using two or more drugs in combination. 
Presenting for treatment The first face-to-face contact between a client and a treatment 
provider.  
Primary drug/substance The substance that brought the client into treatment at the point 
of triage/initial assessment. 
                                            
 
15
 The Children’s Act 1989 can be found here; www.legislation.gov.uk/ukpga/1989/41/contents 
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Psychosocial 
Intervention 
These interventions use psychological, psychotherapeutic, 
counselling and counselling based techniques to encourage 
behavioural and emotional change; the support of lifestyle 
adjustments and the enhancement of coping skills. They 
include motivational interviewing, relapse prevention and 
interventions designed to reduce or stop substance misuse, as 
well as interventions that address the negative impact of 
substance misuse on offending and attendance at education, 
employment or training. 
Referral date The date the client was referred to the provider for this episode 
of treatment. 
Residential unit (not 
substance misuse 
specific) setting 
Anywhere where a young person is receiving interventions in 
their residence but that residence has not been set up 
specifically to deal with substance misuse, such as children’s 
homes, supported housing etc.  
Residential unit 
(substance misuse 
specific) setting 
Anywhere where a young person is receiving interventions in 
their residence and that residence has been set up specifically 
to deal with substance misuse.  
Specialist harm 
reduction intervention 
Care planned substance misuse specific harm reduction is not 
brief advice and information; this intervention must be delivered 
as part of a structured care plan and after a full assessment of 
the young person’s substance misuse and risks. Specialist 
harm reduction interventions should include services to manage 
those at risk of, or currently involved in: 
 
Injecting: these services could include needle exchange, advice 
and information on injecting practice, access to appropriate 
testing and treatment for blood borne viruses 
 
Overdose: advice and information to prevent overdose, 
especially overdose associated with poly-substance use, which 
requires specialist knowledge about substances and their 
interactions 
 
Risky behaviour associated with substance use:  advice and 
information to prevent and/or reduce substance misuse related 
injuries and substance misuse related risky behaviours 
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Structured treatment Structured treatment follows assessment and is delivered 
according to a care plan, with clear goals, which are regularly 
reviewed with the client. It may comprise a number of 
concurrent or sequential treatment interventions.  
Triage An initial clinical risk assessment performed by a treatment 
provider. A triage includes a brief assessment of the problem as 
well as an assessment of the client’s readiness to engage with 
treatment, in order to inform a care plan. 
Triage date The date that the client made a first face-to-face presentation to 
a treatment provider. This could be the date of triage/initial 
assessment though this may not always be the case. 
Waiting times The period from the date a person is referred for a specific 
treatment intervention and the date of the first appointment 
offered. Referral for a specific treatment intervention typically 
occurs within the treatment provider, at or following 
assessment. 
Young people Person under 18 years old. 
YP secure estate Establishments that house young offenders who have been 
remanded or sentenced, they include young offender institutes, 
secure training centres and secure children’s homes. 
Note: full operational definitions can be found in the NDTMS core data set documents on: 
www.nta.nhs.uk/core-data-set.aspx. 
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Appendix A 
Diagram to show an example young people’s pathway  
This diagram illustrates a typical journey through a young people’s specialist substance misuse service. It is provided to give an 
indication of a possible pathway and the interventions received. Pathways will vary depending on the substances used, the 
support requirements of the young people, their general health needs and any other relevant issues. Young people with 
substance misuse problems will usually have a number of other issues that they are receiving help with, but this pathway 
focuses on the substance misuse. 
 
 
